Readnour Robin Shane bought ANTX
February 20, 2026 · Form 4 insider transaction
Readnour Robin Shane bought 20,400 shares of AN2 Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,400
Price
$0.00
Total value
N/A
InsiderReadnour Robin Shane
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 20, 2026
Filing dateFebruary 23, 2026
Shares owned after20,400
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option shares shall vest on February 20, 2027, subject to the Reporting Person providing continuous service through such date.